Cerulean Pharma Inc.
  • Company
    • Management Team
    • Board of Directors
    • Advisors
    • Investors
    • Collaborators
    • Careers
  • Nanopharmaceuticals
    • Platform Overview
    • Supporting Research
  • Pipeline
    • CRLX101
    • CRLX301
    • siRNA Delivery Program
  • News
    • Media Kit

Winning the Fight Against Cancer with Dynamically Tumor-targeted Nanopharmaceuticals.

Cerulean’s nanopharmaceuticals are taken up into tumor cells, where they release their payload. Nanopharmaceuticals are shown in green and tumor cell nuclei in blue.
Message from the CEO

Featured News

Cerulean Pharma to Present Data on CRLX101’s HIF-1α Inhibition at the American Association for Cancer Research Annual Meeting - April 4, 2013
→ View More
Understanding Nanopharmaceuticals
Cerulean Pharma Inc.   Copyright 2013 © All rights reserved.
  • Contact
  • Privacy Policy
  • Terms and Conditions of Use